138 related articles for article (PubMed ID: 9596072)
1. Endothelin A receptor blockade alleviates hypertension and renal lesions associated with chronic nitric oxide synthase inhibition.
Verhagen AM; Rabelink TJ; Braam B; Opgenorth TJ; Gröne HJ; Koomans HA; Joles JA
J Am Soc Nephrol; 1998 May; 9(5):755-62. PubMed ID: 9596072
[TBL] [Abstract][Full Text] [Related]
2. Vitamin E alleviates renal injury, but not hypertension, during chronic nitric oxide synthase inhibition in rats.
Attia DM; Verhagen AMG; Stroes ESG; van Faassen EE; Gröne HJ; De Kimpe SJ; Koomans HA; Braam B; Joles JA
J Am Soc Nephrol; 2001 Dec; 12(12):2585-2593. PubMed ID: 11729226
[TBL] [Abstract][Full Text] [Related]
3. Losartan-sensitive renal damage caused by chronic NOS inhibition does not involve increased renal angiotensin II concentrations.
Verhagen AM; Braam B; Boer P; Gröne HJ; Koomans HA; Joles JA
Kidney Int; 1999 Jul; 56(1):222-31. PubMed ID: 10411696
[TBL] [Abstract][Full Text] [Related]
4. Predisposition of spontaneously hypertensive rats to develop renal injury during nitric oxide synthase inhibition.
Verhagen AM; Koomans HA; Joles JA
Eur J Pharmacol; 2001 Jan; 411(1-2):175-180. PubMed ID: 11137873
[TBL] [Abstract][Full Text] [Related]
5. Female SHR have greater blood pressure sensitivity and renal T cell infiltration following chronic NOS inhibition than males.
Brinson KN; Elmarakby AA; Tipton AJ; Crislip GR; Yamamoto T; Baban B; Sullivan JC
Am J Physiol Regul Integr Comp Physiol; 2013 Oct; 305(7):R701-10. PubMed ID: 23883679
[TBL] [Abstract][Full Text] [Related]
6. Enhanced renal allograft rejection by inhibitors of nitric oxide synthase: a nonimmunologic influence on alloreactivity.
Stojanovic T; Gröne HJ; Gieseler RK; Klanke B; Schlemminger R; Tsikas D; Gröne EF
Lab Invest; 1996 Feb; 74(2):496-512. PubMed ID: 8780167
[TBL] [Abstract][Full Text] [Related]
7. Endothelin and angiotensin mediate most glomerular responses to nitric oxide inhibition.
Qiu C; Baylis C
Kidney Int; 1999 Jun; 55(6):2390-6. PubMed ID: 10354287
[TBL] [Abstract][Full Text] [Related]
8. Unchanged cardiac angiotensin II levels accompany losartan-sensitive cardiac injury due to nitric oxide synthase inhibition.
Verhagen AM; Hohbach J; Joles JA; Braam B; Boer P; Koomans HA; Gröne H
Eur J Pharmacol; 2000 Jul; 400(2-3):239-47. PubMed ID: 10988340
[TBL] [Abstract][Full Text] [Related]
9. Male gender increases sensitivity to proteinuria induced by mild NOS inhibition in rats: role of sex hormones.
Verhagen AM; Attia DM; Koomans HA; Joles JA
Am J Physiol Renal Physiol; 2000 Oct; 279(4):F664-70. PubMed ID: 10997916
[TBL] [Abstract][Full Text] [Related]
10. Renal and vascular effects of chronic nitric oxide synthase inhibition: involvement of endothelin 1 and angiotensin II.
D'Amours M; Lebel M; Grose JH; Larivière R
Can J Physiol Pharmacol; 1999 Jan; 77(1):8-16. PubMed ID: 10535660
[TBL] [Abstract][Full Text] [Related]
11. Vasopressin does not effect hypertension caused by long-term nitric oxide inhibition.
Loichot C; Cazaubon C; Grima M; De Jong W; Nisato D; Imbs JL; Barthelmebs M
Hypertension; 2000 Feb; 35(2):602-8. PubMed ID: 10679504
[TBL] [Abstract][Full Text] [Related]
12. Dysfunctional renal nitric oxide synthase as a determinant of salt-sensitive hypertension: mechanisms of renal artery endothelial dysfunction and role of endothelin for vascular hypertrophy and Glomerulosclerosis.
Barton M; Vos I; Shaw S; Boer P; D'Uscio LV; Gröne HJ; Rabelink TJ; Lattmann T; Moreau P; Lüscher TF
J Am Soc Nephrol; 2000 May; 11(5):835-845. PubMed ID: 10770961
[TBL] [Abstract][Full Text] [Related]
13. Protective effects of angiotensin AT1 receptor blockade in malignant hypertension in the rat.
Therrien F; Lemieux P; Bélanger S; Agharazii M; Lebel M; Larivière R
Eur J Pharmacol; 2009 Apr; 607(1-3):126-34. PubMed ID: 19326569
[TBL] [Abstract][Full Text] [Related]
14. Cortical NOS inhibition raises the lower limit of cerebral blood flow-arterial pressure autoregulation.
Jones SC; Radinsky CR; Furlan AJ; Chyatte D; Perez-Trepichio AD
Am J Physiol; 1999 Apr; 276(4):H1253-62. PubMed ID: 10199850
[TBL] [Abstract][Full Text] [Related]
15. Involvement of nitric oxide in cardioprotective effect of endothelin receptor antagonist during ischemia-reperfusion.
Gourine AV; Gonon AT; Pernow J
Am J Physiol Heart Circ Physiol; 2001 Mar; 280(3):H1105-12. PubMed ID: 11179053
[TBL] [Abstract][Full Text] [Related]
16. Endothelin-1 and relaxation of the rat aorta during pregnancy in nitroarginine-induced hypertension.
Dieye AM; Van Overloop B; Gairard A
Fundam Clin Pharmacol; 1999; 13(2):204-12. PubMed ID: 10226765
[TBL] [Abstract][Full Text] [Related]
17. Neuronal nitric oxide synthase-dependent afferent arteriolar function in angiotensin II-induced hypertension.
Ichihara A; Imig JD; Navar LG
Hypertension; 1999 Jan; 33(1 Pt 2):462-6. PubMed ID: 9931148
[TBL] [Abstract][Full Text] [Related]
18. Different contributions of the endothelin ET(A) receptor to hypertension induced by acute or chronic inhibition of nitric oxide synthesis.
Hashimoto N; Kuro T; Taira S; Matsumura Y
J Pharm Pharmacol; 1998 Sep; 50(9):1051-8. PubMed ID: 9811167
[TBL] [Abstract][Full Text] [Related]
19. Role of endothelin-1 in hypertension induced by long-term inhibition of nitric oxide synthase.
Fujita K; Matsumura Y; Miyazaki Y; Takaoka M; Morimoto S
Eur J Pharmacol; 1995 Jul; 280(3):311-6. PubMed ID: 8566099
[TBL] [Abstract][Full Text] [Related]
20. Role of endothelin ET(A) receptors in the hypertension produced by 4-day L-nitroarginine methyl ester and cyclosporine treatment.
Pollock DM; Polakowski JS; Opgenorth TJ; Pollock JS
Eur J Pharmacol; 1998 Apr; 346(1):43-50. PubMed ID: 9617750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
